Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets

Year 2024, Volume: 54 Issue: 3, 446 - 455, 30.12.2024

Gülşah Karakaya , Sami Hamdoun , Ofcan Oflaz , Berrin Özçelik , Mutlu Dilsiz Aytemir

https://doi.org/10.26650/IstanbulJPharm.2024.1488237

Abstract

Background and Aims: Mycobacterium species cause life-threatening pulmonary and extrapulmonary diseases in humans. This study aimed to evaluate the potential antimycobacterial activity of allomaltol derivatives in the Mannich base structure in vitro and in silico.
Methods: The antimycobacterial activity of each compound against Mycobacterium tuberculosis and Mycobacterium avium was tested using a resazurin microplate assay, and cytotoxicity was assessed using human MRC-5 and He-La cells. Using the SwissTarget tool, Rip1 protease, the metallo-beta-lactamase (MBL) superfamily protein, the serine protease Rv3671c, and zinc metalloprotease 1 (ZMP1) were identified as potential targets. Blind docking was performed for compound 14 using CB-Dock to identify and assess the most probable binding sites on the target proteins. Defined docking was performed with Flare to determine the best binding pose at the predicted binding pocket. The druglikeness of hit compounds, including the partition coefficient, number of hydrogen bond donors/acceptors, molecular refractivity, topological polar surface area (PSA), and gastrointestinal and blood-brain barrier absorption, were evaluated using the SwissADME tool.
Results: Compounds with methyl-substituted piperidine groups were found to have antimycobacterial activity (MICs: 2 μg/mL) against M. avium, which was as potent as the clinically used drugs ethambutol and streptomycin. The predicted physicochemical properties of the four hit compounds were satisfactory. According to the docking results, the binding energies of compound 14, which showed the best overall antimycobacterial activity, ranged from -8.14 to -5.97 kcal/mol, with ZMP1 showing the lowest binding energy.
Conclusion: The results of this study provide evidence that allomaltol derivatives are promising antimycobacterial agents with satisfactory drug profiles.

Keywords

Allomaltol, Tuberculosis, Molecular Docking, Druglikeness

References

• Abdullahi, M., Uzairu, A., Shallangwa, G. A., Arthur, D. E., Umar, B. A., & Ibrahim, M. T. (2020). Virtual molecular docking study of some novel carboxamide series as new anti-tubercular agents. European Journal of Chemistry, 11 (1), 30-36. https://doi.org/10. 5155/eurjchem.11.1.30-36.1955 google scholar
• Amiri, M. R. J., Siami, R., & Khaledi, A. (2018). Tuberculosis Sta-tus and Coinfection of Pulmonary Fungal Infections in Patients Referred to Reference Laboratory of Health Centers Ghaemshahr City during 2007-2017. Ethiopian Journal of Health Sciences, 28(6). https://doi.org/10.4314/ejhs.v28i6.2 google scholar
• Aytemir, M. D., & Çalış, Ü. (2007). Synthesis of Some Novel Mannich Bases Derived From Allomaltol and Evaluation of Their Anticon-vulsant Activities. Hacettepe University Journal of the Faculty of Pharmacy 27(1), 1-10. google scholar
• Aytemir, M.D. & Çalış, Ü. (2006). Synthesis of some new hydrox-ypyranone derivatives and evaluation of their anticonvulsant ac-tivities. FABAD Journal of Pharmaceutical Sciences 31, 23-29. google scholar
• Aytemir, M. D., Çaliş, Ü., & Özalp, M. (2004). Synthesis and Evaluation of Anticonvulsant and Antimicrobial Activities of 3-Hydroxy-6-methyl-2-substituted 4H-Pyran-4-one Derivatives. Archiv Der Pharmazie, 337(5), 281-288. https://doi.org/10.1002/ ardp.200200754 google scholar
• Aytemir, M. D., & Çalış, Ü. (2010). Anticonvulsant and Neuro-toxicity Evaluation of Some Novel Kojic Acids and Allomal-tol Derivatives. Archiv Der Pharmazie, 343(3), 173-181. https: //doi.org/10.1002/ardp.200900236 google scholar
• Aytemir, M. D., & Özçelik, B. (2011). Synthesis and biological ac-tivities of new Mannich bases of chlorokojic acid derivatives. Medicinal Chemistry Research, 20(4), 443-452. https://doi.org/ 10.1007/s00044-010-9338-x google scholar
• Aytemir, M. D., Özçelik, B., & Karakaya, G. (2013). Evaluation of bioactivities of chlorokojic acid derivatives against dermatophytes couplet with cytotoxicity. Bioorganic & Medicinal Chemistry Let-ters, 23(12), 3646-3649. https://doi.org/10.1016/j.bmcl.2013.03. 098 google scholar
• iswas, T., Small, J., Vandal, O., Odaira, T., Deng, H., Ehrt, S., & Tsodikov, O. V. (2010). Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress. Structure (London, England: 1993), 18(10), 1353-1363. https://doi.org/10.1016/j.str.2010.06.017 google scholar
• Brtko, J. (2022). Biological functions of kojic acid and its deriva-tives in medicine, cosmetics, and food industry: Insights into health aspects. Archiv Der Pharmazie, 355(10), 2200215. https://doi.org/10.1002/ardp.202200215 google scholar
• Boyd, S. E., Livermore, D. M., Hooper, D. C., & Hope, W. W. (2020). Metallo-3-Lactamases: Structure, Function, Epidemiol-ogy, Treatment Options, and the Development Pipeline. An-timicrobial Agents and Chemotherapy, 64(10), e00397-20. https: //doi.org/10.1128/AAC.00397-20 google scholar
• Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS) (2006) National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 16th informational supplement. CLSI document M7-A7, 940 West Valley Road, Wayne, Pennsylvania 19087 google scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717 google scholar
• Daina, A., Michielin, O., & Zoete, V. (2019). SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 47(W1),W357-W364. https://doi.org/10.1093/nar/gkz382 google scholar
• Ercan, A., Oncul, S., Karakaya, G., & Aytemir, M. (2020). An al-lomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes. Bioorganic Chemistry, 105, 104403. https://doi.org/10.1016/j.bioorg.2020.104403 google scholar
• Falkinham, J.O. (2018). Mycobacterium avium complex: Adherence as a way of life. AIMS Microbiology, 4(3), 428-438. https://doi. org/10.3934/microbiol.2018.3.428 google scholar
• Ferraris, D. M., Sbardella, D., Petrera, A., Marini, S., Amstutz, B., Coletta, M., Sander, P., & Rizzi, M. (2011). Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity. The Journal of Biological Chemistry, 286(37), 32475-32482. https://doi.org/ 10.1074/jbc.M111.271809 google scholar
• Girase, P. S., Dhawan, S., Kumar, V., Shinde, S. R., Palkar, M. B., & Karpoormath, R. (2021). An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review. European Journal of Medicinal Chemistry, 210, 112967. https://doi.org/10.1016/j.ejmech.2020.112967 google scholar
• Kandioller, W., Kurzwernhart, A., Hanif, M., Meier, S. M., Henke, H., Keppler, B. K., & Hartinger, C. G. (2011). Pyrone derivatives and metals: From natural products to metal-based drugs. Journal of Organometallic Chemistry, 696(5), 999-1010. https://doi.org/10. 1016/j.jorganchem.2010.11.010 google scholar
• Karakaya, G., Aytemir, M. D., Özçelik, B., & Çalış, Ü. (2013). Design, synthesis and in vivo / in vitro screening of novel chlorokojic acid derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(3), 627-638. https://doi.org/10.3109/ 14756366.2012.666538 google scholar
• Karakaya, G., Ercan, A., Oncul, S., & Aytemir, M. D. (2019). Syn-thesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells. Anti-Cancer Agents in Medicinal Chemistry, 18(15), 2137-2148. https://doi.org/10.2174/1871520618666180402141714 google scholar
• Karakaya, G., Türe, A., Ercan, A., Öncül, S., & Aytemir, M. D. (2019). Synthesis, computational molecular docking analysis and effec-tiveness on tyrosinase inhibition of kojic acid derivatives. Bioor-ganic Chemistry, 88, 102950. https://doi.org/10.1016/j.bioorg. 2019.102950 google scholar
• Hull, T. D., Ryu, M. H., Sullivan, M. J., Johnson, R. C., Klena, N. T., Geiger, R. M., Gomelsky, M., & Bennett, J. A. (2012). Cyclic Di-GMP phosphodiesterases RmdA and RmdB are involved in regulating colony morphology and development in Streptomyces coelicolor. Journal of Bacteriology, 194(17), 4642-4651. https: //doi.org/10.1128/JB.00157-12 google scholar
• Liu, Y., Grimm, M., Dai, W., Hou, M., Xiao, Z.-X., & Cao, Y. (2020). CB-Dock: A web server for cavity detection-guided pro-tein-ligand blind docking. Acta Pharmacologica Sinica, 41(1), 138-144. https://doi.org/10.1038/s41401-019-0228-6 google scholar
• Milyutin, C. V., Komogortsev, A. N., Lichitsky, B. V., & Melekhina, V. G. (2023). Acid-catalyzed recyclization of spiroindolinepyrano[3,2- b ]pyrans to 3,4-dihydroquinolinone derivatives containing allomaltol fragment. Journal of Hetero-cyclic Chemistry, 60(8), 1427-1436. https://doi.org/10.1002/jhet. 4690 google scholar
• Motamen, S., & Quinn, R. J. (2020). Analysis of Approaches to Anti-tuberculosis Compounds. ACS Omega, 5(44), 28529-28540. https://doi.org/10.1021/acsomega.0c03177 google scholar
• Oncul, S., Karakaya, G., Dilsiz Aytemir, M., & Ercan, A. (2019). A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design, 94(6), 2084-2093. https://doi.org/10.1111/cbdd.13615 google scholar
• Ozcelik, B., Sheikh, J., Orhan, I. E., Juneja, H., Bennani, B., Kerbal, A., ... Ben Hadda, T. (2013). Outstanding effect of the conformational restriction of isoquinolines: Hints for the development of opti-mized antimicrobial agents. Research on Chemical Intermediates, 39(7), 2955-2962. https://doi.org/10.1007/s11164-012-0808-2 google scholar
• Portell-Buj, E., Vergara, A., Alejo, I., Lopez-Gavm, A., Monte, M. R., San Nicolâs, L., Gonzâlez-Martm, J., & Tudo, G. (2019). In vitro activity of 12 antimicrobial peptides against Mycobacterium tu-berculosis and Mycobacterium avium clinical isolates. Journal of Medical Microbiology, 68(2), 211-215. https://doi.org/10.1099/ jmm.0.000912 google scholar
• Roman, G. (2022). Anticancer Activity of Mannich Bases: A Review of Recent Literature. ChemMedChem, 17(16), e202200258. https: //doi.org/10.1002/cmdc.202200258 google scholar
• Saeedi, M., Eslamifar, M., & Khezri, K. (2019). Kojic acid applica-tions in cosmetic and pharmaceutical preparations. Biomedicine & Pharmacotherapy, 110, 582-593. https://doi.org/10.1016/j. biopha.2018.12.006 google scholar
• Schneider, J. S., Sklar, J. G., & Glickman, M. S. (2014). The Rip1 protease of Mycobacterium tuberculosis controls the SigD regulon. Journal of Bacteriology, 196(14), 2638-2645. https: //doi.org/10.1128/JB.01537-14 google scholar
• Suarez, J., Ranguelova, K., Jarzecki, A. A., Manzerova, J., Kry-mov, V., Zhao, X., ... Magliozzo, R. S. (2009). An Oxyferrous Heme/Protein-based Radical Intermediate Is Catalytically Com-petent in the Catalase Reaction of Mycobacterium tuberculosis Catalase-Peroxidase (KatG). Journal of Biological Chemistry, 284(11), 7017-7029. https://doi.org/10.1074/jbc.M808106200 google scholar
• Venugopala, K. N., Chandrashekharappa, S., Deb, P. K., Tratrat, C., Pillay, M., Chopra, D., ... Mailavaram, R. (2021). Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme. Journal of En-zyme Inhibition and Medicinal Chemistry, 36(1), 1471-1486. https://doi.org/10.1080/14756366.2021.1919889 google scholar
• Zilles, J. C., Dos Santos, F. L., Kulkamp-Guerreiro, I. C., & Contri, R. V. (2022). Biological activities and safety data of kojic acid and its derivatives: A review. Experimental Dermatology, 31(10), 1500-1521. https://doi.org/10.1111/exd.14662 google scholar
• Lv, H., Zhang, X., Zhang, X., Bai, J., You, S., Li, X., ... Xu, Y. (2024). Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC infectious diseases, 24(1), 243. https: //doi.org/10.1186/s12879-024-09079-5 google scholar